scGNN is a novel graph neural network framework for single-cell RNA-Seq analyses.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The primary study’s scGNN integrates single-cell RNA-seq modalities and reports Alzheimer’s disease-associated oligodendrocyte-subcluster shifts, gene/pathway enrichments and cell-specific regulatory programs. This is an exploratory reanalysis of existing data, not causal or independently experimentally confirmed biology.
Technology: Author/university full primary PDF, Methods/Results and Nature record checked: GSE138852, 13,214 nuclei from six AD and six control brains. Correction dated 2022-05-04 only swaps figure panels and does not alter the result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Author/university full primary PDF, Methods/Results and Nature record checked: GSE138852, 13,214 nuclei from six AD and six control brains. Correction dated 2022-05-04 only swaps figure panels and does not alter the result.
- Limitation / still unknown
- This is exploratory reanalysis of existing single-cell data; the reported cell programs are not causal or independently experimentally confirmed.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://bpb-us-w2.wpmucdn.com/u.osu.edu/dist/0/72768/files/2021/03/Wang_et_al-2021-Nature_Communications-1.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.